1. Home
  2. GT vs OGN Comparison

GT vs OGN Comparison

Compare GT & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Goodyear Tire & Rubber Company

GT

The Goodyear Tire & Rubber Company

HOLD

Current Price

$6.29

Market Cap

2.0B

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$6.20

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GT
OGN
Founded
1898
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Automotive Aftermarket
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
GT
OGN
Price
$6.29
$6.20
Analyst Decision
Hold
Hold
Analyst Count
5
4
Target Price
$10.56
$11.75
AVG Volume (30 Days)
7.4M
3.1M
Earning Date
05-06-2026
04-30-2026
Dividend Yield
N/A
1.28%
EPS Growth
N/A
N/A
EPS
N/A
0.72
Revenue
$18,280,000,000.00
$6,216,000,000.00
Revenue This Year
N/A
$0.42
Revenue Next Year
$3.38
$1.67
P/E Ratio
N/A
$8.65
Revenue Growth
N/A
N/A
52 Week Low
$6.36
$6.16
52 Week High
$12.03
$15.85

Technical Indicators

Market Signals
Indicator
GT
OGN
Relative Strength Index (RSI) 19.60 28.91
Support Level N/A $6.18
Resistance Level $8.75 $7.87
Average True Range (ATR) 0.30 0.19
MACD -0.11 -0.02
Stochastic Oscillator 2.00 3.69

Price Performance

Historical Comparison
GT
OGN

About GT The Goodyear Tire & Rubber Company

Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment. The company operates its business through three operating segments representing its regional tire businesses: Americas; Europe, the Middle East, and Africa (EMEA); and the Asia Pacific.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: